Profile: Elan Corporation, Plc is a neuroscience-based biotechnology company. We focus on developing, manufacturing and marketing advanced therapies in neurology and autoimmune diseases. We develop three therapeutic approaches like immunotherapy, beta secretase inhibitors and gamma secretase inhibitors. Immunotherapy targets the clearance of beta-amyloid and the peptide responsible for the build-up of amyloid plaques in the brain. Our products include Prialt®, Azactam® and Maxipime®.